Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial

BACKGROUND: This study sought to evaluate and compare the effectiveness of plasmapheresis, Tocilizumab, and Tocilizumab with plasmapheresis treatment on the removal of inflammatory cytokines and improvement clinically of patients with severe COVID-19 in Intensive Care Units (ICU) due to the associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gholinataj jelodar, Mohsen, Rafieian, Shahab, Saghafi, Fatemeh, Hadad zedegan, Navid, Birjandi, Behnaz, Rafieian, Shiva, Allah dini, Azadeh, Dehghanpour, Hanieh, Khalaj, Fatemeh, Zare, Samira, Dehghan Chenari, Hanieh, Hajimaghsoudi, Majid, Mojtaba Sohrevardi, Seyed, Mirzaei, Samaneh, Jamialahmadi, Tannaz, Atkin, Stephen L., Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767880/
https://www.ncbi.nlm.nih.gov/pubmed/36577157
http://dx.doi.org/10.1016/j.intimp.2022.109623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767880/
https://www.ncbi.nlm.nih.gov/pubmed/36577157
http://dx.doi.org/10.1016/j.intimp.2022.109623

Ejemplares similares